Endocrinology, Diabetes and Metabolism

Pioneering research conducted and advanced by Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, played a key role in the European Commission’s decision to approve dapagliflozin for patients with Type 1 diabetes.

The Clinical and Translational Science Institute (CTSI) has recognized two Jacobs School of Medicine and Biomedical Sciences faculty members for their clinical research work.

Twenty faculty members with a variety of clinical and research experience — representing nine medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences during the past several months.

Paresh Dandona, MD, PhD — who did the first pilot studies on how drugs developed for Type 2 diabetes patients might benefit adults with Type 1 diabetes — is launching a major, interventional study with 114 patients in Buffalo and Glasgow, Scotland.

Twelve projects and their researchers were recognized as best in their respective categories during the Department of Medicine’s sixth annual Research Day.

Research led by Paresh Dandona, MD, PhD, has shown that adding liraglutide to insulin treatment for patients with Type 1 diabetes provides health benefits.